Roundtable Discussion: Advancing EEG Biomarkers to Enhance Translational Precision in Neuropsychiatric Drug Development
- Leveraging EEG and complementary neurophysiology approaches to map circuit level modulation and therapeutic mechanisms
- Combining immediate early gene readouts, single unit recordings, and local field potentials to construct multi modal circuit signatures
- Building translational frameworks that bridge preclinical circuit modulation to human biomarker endpoints
- Advancing biomarker driven decision making to de risk development and guide dose selection, target engagement, and clinical translatability